Iain Miller, EPEMED board member, and Jorge Mestre-Ferrandiz, OHE Director of Consulting, will co-present the methodology and results of the OHE EPEMED 2016 study, "Value of Knowing and Knowing of Value: the need for an expanded value framework for complementary diagnostics”, on the 12th of Sep 16 from 17:55 to18:25 GMT.

Iain Miller will attend and moderate on July 12th the session “The Critical role of Biomarkers and Companion Diagnostics Development”. For more information, email at contact@epemed.org.

Emmanuelle Benzimra, Executive Director, will be attending the conference. Contact her at contact@epemed.org

Alain Huriez, EPEMED President, will chair the EASL-EPEMED Joint Workshop "Personalised Biomarkers in liver disease” in London on April 9th / 08:00-11:00am

Emmanuelle Benzimra, Executive Director, will be attending the conference. Contact her at contact@epemed.org.

Mara Aspinall, EPEMED vice-president, will introduce the preliminary results and methodology of the OHE EPEMED 2015 study, “HTA of complementary diagnostics : issues, options and opportunities”, at the PMWC conference, on the 25th of Jan 16, in Silicon Valley, track 4 (Personalised Medicine and Diagnostics Beyond the USA)

Alain Huriez, EPEMED President, will be a panelist on the session “Changing the face of cancer care - the impacts of personalised medicine on diagnostics and treatments”

Emmanuelle Benzimra, EPEMED General Delegate will chair the session « adressing known obstacles to integrating PM into health systems ».

Personalized Medicine & Cancer Biomarker

Iain Miller, EPEMED board member and Secretary, will share as a speaker insight over oncology, personalised medicine and biomarkers

Personalised Medicine 2015

Iain Miller, EPEMED board member and Secretary, will chair the afternoon sessions

Quel modèle économique pour la médecine personnalisée ?

Pablo Jordan, EPEMED Board Member, will be a panelist on the third session : "Les comparaisons avec des modèles économiques européens".

Personalized Medicine World Conference

Emmanuelle Benzimra, EPEMED General Delegate, will attend as a partner of the conference in Oxford

>>>Read more

Access a replay of the EPEMED sessions
>>> Watch videos

EPEMED chairs the workgroup "Education, let's start again: requirements to fix undeveloped PM education structures" on October 21st from 14.30 to 17.30.

Alain Huriez will co-chair therapeutic panel "Personalised Medicine & Diagnostics on September 30th

Invitation-Only roundtable: Closing the Gaps in Personalised Medicine for Lung Cancer
EPEMED is a panelist at the Pfizer Oncology half-day roundtable on September 29, 2014 from 1 PM to 4 PM during the European Cancer Congress (ECCO/ESMO) in Madrid, Spain

EPEMED is part of EuroBioForum Scoping Session ‘Education & Training’ in Personalised Medicine on September 23rd.

EPEMED will be present at the BIO International Convention - the largest global event for the biotech industry - from 23-26 June 2014 in San Diego, US. Alain Huriez, EPEMED President, will be chairing the roundtable “Making Personalized Medicine a Global Reality for Everyone, Anywhere, Anytime”, Thursday 26/06, 2:15 PM to 3:30 PM, Room 7AB San Diego Convention Center.

A session hosted by FlandersBio, the networking organisation for the life sciences sector in Flanders - Belgium, and Flanders Investment & Trade, featuring:
Iain Miller (Healthcare Strategies Group and EPEMED member), Rudi Pauwels (Biocartis), Werner Verbiest (Janssen Diagnostics and EPEMED member)
• Success stories on how to overcome the challenges when engaging in
personalised medicine
• New business models that speed up the global implementation of personalised
medicine
• A discussion on value-based pricing and reimbursement of diagnostic tests in
both the US and Europe

>>>Website

Peter Collins, EPEMED Board Member, will chair the morning session DAY 1 Stream 1 "strategies to enable successful implementation of Precision Medicine". Emmanuelle Benzimra, EPEMED General Delegate, will attend the conference.

>>>Website

Iain Miller, EPEMED board member and Secretary, will chair the panel ” Will companion Dx exist in 2020? “The transition from single CDx paradigms to multi-omic testing”, London on May 13th / 13:30-14:20

>>> Website

Iain Miller, EPEMED Board Member and Secretary, will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”, on April 23rd / 03:00-03:30pm

>>> Website

Dr. Stefan N. Willich, MPH MBA, Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin and Emmanuelle Benzimra, EPEMED General Delegate, will both attend workshop.

>>> Website

Markus Bücheler, MD, Institute for Social Medicine, Epidemiology, and Health Economics Charité - Universitätsmedizin Berlin, will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”

>>> Website

Prof. Dr. med. Bernd Brüggenjürgen, coordinator for Health Systems Research at the Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, will be a discussion partner of the "patient benefit vs. cost containment, how to measure the value of innovation?" on the 21.3.14.

>>> Website

Prof. Dr. med. Bernd Brüggenjürgen, coordinator for Health Systems Research at the Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin , will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”

>>> Website